May 18, 2026
Why Indirect Healthcare Costs Deserve Greater Attention
Many reimbursement decisions still overlook indirect healthcare costs. These expenses arise from lost…
May 11, 2026
Building Effective Biosimilar Portfolios
The US biosimilar market has matured significantly, moving beyond single-product competition toward comprehensive…
May 4, 2026
US Oncology Innovation Sets New Standards for Cancer Care
The United States continues to lead the world in cancer research through consistent…
April 27, 2026
How US Drug Pricing Reforms Are Reshaping Innovation
US drug pricing reforms have fundamentally altered the economics of biopharmaceutical innovation. Multiple…
April 20, 2026
Reforming the Accelerated Approval Pathway
The accelerated approval pathway has transformed access to treatments for serious conditions since…
April 13, 2026
Lenacapavir PrEP Marks New Chapter in South African HIV Prevention
The recent arrival of lenacapavir PrEP in South Africa signals a notable advance…